浏览全部资源
扫码关注微信
阻断Kupffer细胞TIM-4诱导iTreg细胞的产生影响小鼠肝移植免疫耐受
Inhibiting TIM-4 function in Kupffer cells induces iTreg cell proliferation and thus immune tolerance in mice after liver transplantation
- 第三军医大学学报 2017年39卷第2期 页码：143-150
- 作者机构：
400010 重庆, 重庆医科大学附属第二医院肝胆外科
- 作者简介：
龚建平, E-mail: gongjianping11@126.com Gong Jianping, E-mail: gongjianping11@126.com
- 基金信息：国家自然科学基金面上项目(81370580);国家自然科学基金青年科学基金(81300364)
DOI：10.16016/j.1000-5404.201607147
中图分类号： R392.2;R392.4;R657.3纸质出版日期：2017-1-30，
收稿日期：2016-7-22，
录用日期：2016-10-11
扫 描 看 全 文
吴皓, 徐雪松, 吴涯昆, 等. 阻断Kupffer细胞TIM-4诱导iTreg细胞的产生影响小鼠肝移植免疫耐受[J]. 第三军医大学学报, 2017,39(2):143-150.
Hao Wu, Xuesong Xu, Yakun Wu, et al. Inhibiting TIM-4 function in Kupffer cells induces iTreg cell proliferation and thus immune tolerance in mice after liver transplantation[J]. J Third Mil Med Univ, 2017,39(2):143-150.
吴皓, 徐雪松, 吴涯昆, 等. 阻断Kupffer细胞TIM-4诱导iTreg细胞的产生影响小鼠肝移植免疫耐受[J]. 第三军医大学学报, 2017,39(2):143-150. DOI： 10.16016/j.1000-5404.201607147.
Hao Wu, Xuesong Xu, Yakun Wu, et al. Inhibiting TIM-4 function in Kupffer cells induces iTreg cell proliferation and thus immune tolerance in mice after liver transplantation[J]. J Third Mil Med Univ, 2017,39(2):143-150. DOI： 10.16016/j.1000-5404.201607147.
摘要
目的
2
探讨阻断Kupffer细胞(Kupffer cells， KCs)T细胞免疫球蛋白黏蛋白4(T-cell immunoglobulin and mucin-domain-containing molecule 4， TIM-4)诱导小鼠原位肝移植术后iTreg细胞的产生及其相关机制。
方法
2
建立小鼠原位肝移植急性排斥反应模型，分为sham组、control mAb组、TIM-4 mAb组。流式细胞仪检测KCs活化，Western blot检测肝脏TIM-4表达，TUNEL检测肝细胞凋亡指数(apoptotic index，AI)。提取KCs，激光共聚焦检测KCs TIM-4表达，将KCs和提取的初始CD4
+
T细胞进行共培养，激光共聚焦检测Kupffer细胞TIM-4表达，分为control组、control mAb组以及TIM-4 mAb组；CFSE检测CD4
+
T细胞增殖，流式细胞仪检测CD4
+
CD25
+
Foxp3
+
T细胞，ELISA检测IL-4、IL-6、IL-13水平，Western blot检测STAT6表达。建立小鼠移植模型，分为3组：iTreg组移植模型注入iTreg细胞(预先用TIM-4 mAb处理的TIM-4
+
KCs与初始CD4
+
T细胞共培养所诱导)，sham组和单纯肝移植组(LT)注入相应的PBS作为对照，检测各组AST、ALT、TBIL水平，HE染色评价肝组织排斥活动指数(rejective activity index，RAI)，观察小鼠生存率。
结果
2
肝移植术后24、48、72 h KCs的活化分别为15.9%、21.6%、28.3%，术后1、3、7 d TIM-4蛋白表达水平明显高于sham组(
P
＜0.05)；control mAb组AI值(29.23±2.56)明显高于sham组和TIM-4 mAb组 。KCs与CD4
+
T细胞共培养后， control、control mAb以及TIM-4 mAb组CD4
+
T细胞的增殖率分别为32.5%、31.6%、 17.2%，CD4
+
CD25
+
Foxp3
+
T细胞分化分别为12.4%、13.9%、28.1%，共培养上清液TIM-4 mAb组IL-4、IL-6、IL-13 分泌水平明显低于control mAb(
P
＜0.05)，且加入TIM-4 mAb明显降低了与TIM-4
+
KCs共培养的CD4
+
T细胞p-STAT6蛋白表达(
P
＜0.05)，外源性加入IL-4可明显增高CD4
+
T细胞p-STAT6蛋白的表达(
P
＜0.05)。移植模型注入iTreg细胞，iTregz组肝功指标明显好转，与LT组比较差异有统计学意义(
P
＜0.05)。肝组织病理学检查，iTreg组RAI平均得分为(3.97±0.67)，明显低于LT组 ，且iTreg组小鼠平均存活时间延长。
结论
2
阻断KCs TIM-4能够抑制初始CD4
+
T细胞IL-4/STAT6信号通路的激活，从而诱导更多iTreg细胞的生成，致使宿主对移植物产生免疫耐受。
Abstract
Objective
2
To determine the effect of inhibiting T-cell immunoglobulin and mucin-domain-containing molecule 4 (TIM-4) function in Kupffer cells (KCs) on the proliferation in iTreg cells after liver transplantation in mice and the relevant mechanism.
Methods
2
The mouse models of orthotopic liver transplantation were established
and the mice were divided randomly into 3 groups: sham group
control mAb group
and TIM-4 mAb group. The number of activated KCs was assayed by flow cytometry. The expression of TIM-4 in the liver tissues was assayed by Western blotting
and the apoptotic index (AI) was analyzed by TUNEL assay. KCs were extracted from the liver. The expression of TIM-4 in the KCs was observed by laser confocal microscopy. The KCs and naive CD4
+
T cells were co-cultured
and then divided into 3 groups: control group
control mAb group
and TIM-4 mAb group. The proliferation of naive CD4
+
T cells was assayed with CellTrace CFSE cell proliferation kit. Furthermore
the number of CD4
+
CD25
+
Foxp3
+
T cells was assayed by flow cytometry. The levels of IL-4
IL-6 and IL-13 were assayed by ELISA
and the protein level of p-STAT6 in T cells was assayed by Western blotting. Then
the mice in the iTreg group were injected with iTreg cells
which were induced with co-culture system of KCs treated with TIM-4mAb and naive CD4
+
T cells through portal vein. The sham group and liver transplantation (LT) group were treated with commensurable PBS. In 7 d after operation
the serum levels of AST
ALT and TBIL were tested in each group. The liver tissues in each group were stained with HE to observe the rejective activity index (RAI) under light microscope. The survival time of the mice was observed.
Results
2
The ratios of activated KCs after liver transplantation at 24
48 and 72 h were 15.9%
21.6% and 28.3%
respectively
and the protein level of TIM-4 in liver tissues was significantly higher than that in the sham group in 1
3 and 7 d after operation (
P
＜0.05). The AI (29.23±2.56) of the control mAb group was significantly higher than that (0.40±0.49) in sham group
and that (11.04±2.28) of TIM-4 mAb group (
P
＜0.05). Then
after KCs and naive CD4
+
T cells were co-cultured
the growth ratios of CD4
+
T cells were 32.5%
31.6% and 17.2%
respectively in the control
control mAb and TIM-4 mAb groups
and the differentiation ratios of CD4
+
CD25
+
Foxp3
+
T cells were 12.4%
13.9%
and 28.1%
respectively. The IL-4
IL-6 and IL-13 levels in TIM-4 mAb group were significantly lower than those in control mAb group (
P
＜0.05). However
the addition of TIM-4 antibody blocked the increased expression of p-STAT6 in CD4
+
T cells co-cultured with TIM-4
+
KCs but not in the cells co-cultured with TIM-4- KCs (
P
＜0.05). Furthermore
exogenous IL-4 was added to the co-culture model and overwhelmed the inhibition of p-STAT6 expression by TIM-4 mAb (
P
＜0.05). After injection of iTreg cells through the portal vein
the index of liver function in the iTreg group was improved compared with the LT group (
P
＜0.05). And the mean RAI score in the iTreg group was 3.97±0.67
which was significant lower than 8.47±0.90 in the LT group (
P
＜0.05). The survival time of the iTreg group was markedly prolonged.
Conclusion
2
The blockade of TIM-4 function in Kupffer cells can inhibit the activation of IL-4/STAT6 signaling and induce proliferation of iTreg cells
and as a result
better immune tolerance is induced after liver transplantation.
关键词
T细胞免疫球蛋白黏蛋白4Kupffer细胞Treg细胞白介素4肝移植
Keywords
T-cell immunoglobulin and mucin-domain-containing molecule 4Kupffer cellsTreg cellsinterleukin-4liver transplantation
references
McIntire J J, Umetsu S E, Akbari O, et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family[J]. Nat Immunol, 2001, 2(12): 1109-1116.
Li Z, Ju Z, Frieri M. The T-cellimmunoglobulin and mucin domain (Tim) gene family in asthma[J]. Allergy Asthma Proc, 2013, 34(1): e21-26. DOI: 10.2500/aap.2013.34.3646
Fang X Y, Xu W D, Pan H F, et al. Novel insights into Tim-4 function in autoimmune diseases[J]. Autoimmunity, 2015, 48(4): 189-195. DOI: 10.3109/08916934.2014.983266
Meyers J H, Sabatos C A, Chakravarti S, et al. The TIM gene family regulates innate and adaptive immunity[J]. Trends Mol Med, 2005, 11(8): 362-269
Zhao C Q, Li T L, He S H, et al. Specific immunotherapy suppresses Th2 responses via modulating TIM1/TIM4 interaction on dendritic cells[J]. Allergy, 2010; 65(8): 986-995. DOI: 10.1111/j.1398-9995.2009.02295.x
Chen G S, Qi H Z. Effect of Kupffer cells on immune tolerance in liver transplantation[J]. Asian Pac J Trop Med, 2012; 5(12): 970-972. DOI: 10.1016/S1995-7645(12)60184-9
Dai L L, Gong J P, Zuo G Q, et al. Synthesis of endotoxin receptor CD14 protein in Kupffer cells and its role in alcohol-induced liver disease[J]. World J Gastroenterol, 2003, 9(3): 622-626
Thomson A W, Knolle P A. Antigen-presenting cell function in the tolerogenic liver environment[J]. Nat Rev Immunol, 2010, 10(11): 753-766. DOI: 10.1038/nri2858
Toscano M A, Bianco G A, Ilarregui J M, et al. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death[J]. Nat Immunol, 2010, 8(8): 825-834.
Biswas M, Terhorst C, Herzog R W. Treg: tolerance vs immunity[J]. Oncotarget, 2015, 6(24): 19956-19957.
Hou X, Song J, Su J, et al. CD4+Foxp3+ Tregs protect against innate immune cell-mediated fulminant hepatitis in mice[J]. Mol Immunol, 2015, 63(2): 420-427. DOI: 10.1016/j.molimm.2014.09.015
Knechtle S J, Kwun J. Unique aspects of rejection and tolerance in liver transplantation[J]. Semin Liver Dis, 2009, 29(1): 91-101. DOI: 10.1055/s-0029-1192058
Rong S, Park J K, Kirsch T, et al. The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury[J]. J Am Soc Nephrol, 2011, 22(3): 484-495. DOI: 10.1681/ASN.2010030321
Tietjen G T, Gong Z, Chen C H, et al. Molecular mechanism for differential recognition of membrane phosphatidylserine by the immune regulatory receptor Tim4[J]. Proc Natl Acad Sci U S A, 2014, 111(15): E1463-1472. DOI: 10.1073/pnas.1320174111
Abe Y, Kamachi F, Kawamoto T, et al. TIM-4 has dual function in the induction and effector phases of murine arthritis[J]. J Immunol, 2013, 191(9): 4562-4572. DOI: 10.4049/jimmunol.1203035
Zhao C Q, Li T L, He S H, et al. Specific immunotherapy suppresses Th2 responses via modulating TIM1/TIM4 interaction on dendritic cells[J]. Allergy, 2010, 65(8): 986-995. DOI: 10.1111/j.1398-9995.2009.02295.x
Yeung M Y, McGrath M M, Nakayama M, et al. Interruption of Dendritic Cell-Mediated TIM-4 Signaling Induces Regulatory T Cells and Promotes Skin Allograft Survival[J]. J Immunol, 2013, 191(8): 4447-4455. DOI: 10.4049/jimmunol.1300992
Chapoval S, Dasgupta P, Dorsey N J, et al. Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6[J]. J Leukoc Biol, 2010, 87(6): 1011-1018. DOI: 10.1189/jlb.1209772
Mantel P Y, Kuipers H, Boyman O, et al. GATA3-driven Th2 responses inhibit TGF-β1-induced FOXP3 expression and the formation of regulatory T cells[J]. PLoS Biol, 2007, 5(12): e329.
0
浏览量
0
下载量
0
CSCD
- 网络PDF下载
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
